| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Physiology and Functional Genomics (J.Y.C., M.T., L.E.B., M.L.G., H.K.), University of Florida College of Medicine, Gainesville, Fla; Cardiology Division (J.T.L.), University of California, San Francisco; Department of Radiation Oncology (N.H.), Washington University School of Medicine, St Louis, Mo; Cardiovascular Research (E.O.W.), Boston University Medical Center, Boston, Mass; Department of Molecular Cardiovascular Biology (H.A.), Yamaguchi University School of Medicine, Ube, Japan; Department of Biology (N.S.), Faculty of Science, Chiba University, Chiba, Japan; and Cardiovascular Research Center (K.R.C.), Massachusetts General Hospital, Boston.
Correspondence to Hideko Kasahara, MD, PhD, Department of Physiology and Functional Genomics, University of Florida College of Medicine, 1600 SW Archer Rd, Gainesville, FL 32610-0274. E-mail hkasahar{at}phys.med.ufl.edu
Two myosin light chain (MLC) kinase (MLCK) proteins, smooth muscle (encoded by mylk1 gene) and skeletal (encoded by mylk2 gene) MLCK, have been shown to be expressed in mammals. Even though phosphorylation of its putative substrate, MLC2, is recognized as a key regulator of cardiac contraction, a MLCK that is preferentially expressed in cardiac muscle has not yet been identified. In this study, we characterized a new kinase encoded by a gene homologous to mylk1 and -2, named cardiac MLCK, which is specifically expressed in the heart in both atrium and ventricle. In fact, expression of cardiac MLCK is highly regulated by the cardiac homeobox protein Nkx2-5 in neonatal cardiomyocytes. The overall structure of cardiac MLCK protein is conserved with skeletal and smooth muscle MLCK; however, the amino terminus is quite unique, without significant homology to other known proteins, and its catalytic activity does not appear to be regulated by Ca2+/calmodulin in vitro. Cardiac MLCK is phosphorylated and the level of phosphorylation is increased by phenylephrine stimulation accompanied by increased level of MLC2v phosphorylation. Both overexpression and knockdown of cardiac MLCK in cultured cardiomyocytes revealed that cardiac MLCK is likely a new regulator of MLC2 phosphorylation, sarcomere organization, and cardiomyocyte contraction.
Key Words: kinase transcription contraction
Related Article:
Circ. Res. 2008 102: 516-518.
This article has been cited by other articles:
![]() |
J. Huang, J. M. Shelton, J. A. Richardson, K. E. Kamm, and J. T. Stull Myosin Regulatory Light Chain Phosphorylation Attenuates Cardiac Hypertrophy J. Biol. Chem., July 11, 2008; 283(28): 19748 - 19756. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishikawa and R. Kurotani Cardiac Myosin Light Chain Kinase: A New Player in the Regulation of Myosin Light Chain in the Heart Circ. Res., March 14, 2008; 102(5): 516 - 518. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |